Nasopharyngeal Cancer

• CLINICAL_TRIALS research · 2014-06-06
  Clinical Trial Update: Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer [Phase 1]

  This Phase 1 clinical trial update examines a combination regimen of Erlotinib, Docetaxel, and radiation therapy for locally advanced head a…

• CLINICAL_TRIALS research · 2014-04-17
  Clinical Trial Update: Swallowing Exercises for Nasopharyngeal Cancer After Radiation Therapy [NA]

  A completed clinical trial studying swallowing exercises for nasopharyngeal cancer patients with dysphagia after radiation therapy. The snip…

• CLINICAL_TRIALS research · 2014-01-22
  Clinical Trial Update: A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal Cancer

  This clinical trial update discusses a study investigating lymphangiogenesis in colorectal cancer and nasopharyngeal cancer. The trial statu…

• CLINICAL_TRIALS research · 2013-12-19
  Clinical Trial Update: Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx [Phase 3]

  Phase 3 trial comparing radiation therapy alone to radiation therapy plus chemotherapy in patients with previously untreated nasopharyngeal …

• CLINICAL_TRIALS research · 2013-08-22
  Clinical Trial Update: Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer [NA]

  This clinical trial update discusses evaluating a different sequence of chemoradiotherapy and a modified radiotherapy schedule for advanced …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2013-05-15
  Clinical Trial Update: Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer [Phase 2]

  Phase 2 trial evaluating fluorouracil, cisplatin, and radiation therapy for nasopharyngeal cancer.

• CLINICAL_TRIALS research · 2013-03-29
  Clinical Trial Update: Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis [Phase 2]

  Phase 2 clinical trial evaluating recombinant human GM-CSF (rhGM-CSF) for treating oral mucositis in patients with nasopharyngeal cancer; cu…